|Ho: Enhancing Innate Immune Activation
|Prophylactic neutralizing Ab
|Study Start Date:
|Study Made Public:
Screen for broadly neutralizing sera among Dr. Bruce Walker’s Massachusetts General Hospital HIV+ Patient Cohort in Boston [Original Study Title: Walker 1 and Walker 2]
CAVD 290 is an immunogenicity study to evaluate and characterize the neutralization activity of broadly neutralizing antibodies from humans in HIV controllers.
Sign in to see full information about this study and to download study data.
ProductsNo Products used in study
No integrated data is available for this study.
No non-integrated data is available for this study.